Khalil Khalid, Hodson James, Anderson Benjamin, Nath Jay, Sharif Adnan
Institute of Immunology and Immunotherapy, University of Birmingham, Birminghamn, United Kingdom.
Institute of Translational Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom.
Transplant Direct. 2018 Oct 17;4(11):e399. doi: 10.1097/TXD.0000000000000834. eCollection 2018 Nov.
The aim of this study was to compare posttransplant outcomes of kidney allograft recipients between those followed up at transplant centers and those that were repatriated back to referral renal units.
We analyzed data for 1375 consecutive patients transplanted in a single center in the United Kingdom. Patients were stratified into 3 groups: (1) externally referred patients with repatriation back for external follow-up (repatriated, n = 463), (2) externally referred patients not repatriated and followed-up internally at transplant center (nonrepatriated, n = 365), and (3) internally referred patients within transplant center with continued internal transplant center follow-up (internal, n = 547). Patient and death-censored graft survival were compared between groups on both univariable and multivariable analyses.
Baseline comparisons found that the nonrepatriated group had increased risk for prolonged length of stay and delayed graft function compared with repatriated patients. The nonrepatriated group had significantly shorter survival compared to the repatriated patients (90.2% vs 94.1% at 5 years, = 0.013), which persisted after adjustment for confounders on multivariable analysis (hazard ratio, 1.86; 95% confidence interval, 1.06-3.28; = 0.032). Death-censored graft survival was not found to differ significantly between the 3 groups ( = 0.192).
Our results provide reassurance regarding repatriation of care after kidney transplantation for the United Kingdom. Nonrepatriated patients are identified as a high-risk group for increased mortality, but further investigation is warranted to probe this heterogeneous group and validate in a non-United Kingdom cohort.
本研究旨在比较肾移植受者在移植中心接受随访与被遣返回转诊肾单位的患者移植后的结局。
我们分析了在英国一个单一中心连续接受移植的1375例患者的数据。患者被分为3组:(1)外部转诊且被遣返回外部进行随访的患者(遣返组,n = 463),(2)外部转诊但未被遣返且在移植中心接受内部随访的患者(未遣返组,n = 365),以及(3)在移植中心内部转诊且继续在移植中心接受内部随访的患者(内部组,n = 547)。在单变量和多变量分析中比较了各组患者及死亡删失后的移植物存活率。
基线比较发现,与遣返患者相比,未遣返组住院时间延长和移植肾功能延迟的风险增加。未遣返组的生存率明显低于遣返患者(5年时分别为90.2%和94.1%,P = 0.013),在多变量分析中对混杂因素进行调整后这一差异仍然存在(风险比,1.86;95%置信区间,1.06 - 3.28;P = 0.032)。未发现3组之间死亡删失后的移植物存活率有显著差异(P = 0.192)。
我们的结果为英国肾移植后护理的遣返提供了依据。未遣返患者被确定为死亡率增加的高危人群,但有必要进一步调查以探究这一异质性群体并在非英国队列中进行验证。